Abstract: Insertional mutagenesis is a productive strategy for the exploration of genetic regulation of important biological and pathological processes, such as tumorigenesis. Successful implementation of this strategy depends heavily on an efficient approach to the identification of insertion sites present in the host genome. Here, we have introduced an easy and efficient protocol, called Adenosine-ended Primer Extension Polymerase Chain Reaction (APE-PCR), which represents several advantages, including the Addition technique we previously developed, primer extension approach coupled with biotin-streptavidin based purification, introduction of nano-scale magnetic particles, and digestion of DNA with a combination of enzymes. We have demonstrated that APE-PCR is able to amplify more and larger specific proviral insertion site (PIS)-derived fragments, with a lower non-specific background produced, fewer steps and less DNA samples required, flexibility in choice of restriction enzymes applied, at a lower cost. Replacement of regular magnetic beads with nano-scale ones in the protocol can further increase its power. Moreover, even with small amount of sample DNA, PISs can be recovered and analyzed. Thus, based on the results provided from this study, we believe that APE-PCR represents an efficient method in mapping of PISs and likely, the insertion sites of other types of DNA elements as well.
Introduction
The availability of whole genome sequences of human and major model organisms has greatly facilitated life sciences and biotechnology moving into the era of functional genomics (Lander et al. 2001; Venter et al. 2001) . As more organisms of biomedical and industrial significances are sequenced, one important and interesting long-standing task has been to understand what information these sequences carry and how they impact cellular processes, individual health and behavior, and even biological evolution. Insertional mutagenesis has been demonstrated to be a fruitful strategy for functional genomics research in many species (Skarnes et al. 2004; Corey & Largaespada 2005) . Over the past decade we have witnessed the use of this strategy in the exploration of tumor related genetic events that are involved in the regulation of aspects of cellular activities, including cell cycle, proliferation, differentiation, programmed cell death, and senescence (Mikkers & Berns 2003; Vassiliou et al. 2011) . The development of methods for the identification of insertion sites of a given mutagen under study has been at the core of the strategy. Among various methods developed, ligation-mediated polymerase chain reaction (PCR)-based approaches, genome walking strategies, have been successful for the investigation of different insertional mutagens, such as retroviruses and transposons Yin et al. 2009; Leoni et al. 2011; Vassiliou et al. 2011; Pérez-Mancera et al. 2012) .
We have previously reported the developments of SplinkBlunt-PCR and STA-PCR protocols, for the isolation of proviral insertion sites (PISs) (Yin & Largaespada 2007; Yin 2011) . These PCR methods have been adopted to map a large amount of PISs present in leukemia cells derived from BXH-2 mice (Yin et al. 2009 ). BXH-2 recombinant inbred mice spontaneously produce a B-tropic murine leukemia virus (MuLV) beginning early in life. The BXH-2 MuLV not only acts as an insertional DNA mutagen to cause leukemia, but also serves as a tag for leukemia-associated genes (Jenkins et al. 1982; Largaespada 2000; Yin 2011 ). Therefore, leukemia-associated genetic aberrations can be examined by mapping PISs of BXH-2 MuLV in tumor samples that develop from these mice. To achieve maximum recovery of PISs, however, it has been suggested that both of PCR procedures be performed for each tumor sample. This not only requires cumbersome manipulations, but also consumes a larger quantity of DNA samples, availability of which is often limited. Thus, it is desirable to design and evaluate new methods that can be used to efficiently study PISs and the insertion sites of other types of DNA elements as well.
Here, we have developed a novel protocol, called Adenosine-ended Primer Extension Polymerase Chain Reaction (APE-PCR), representing several advantages, including the Addition technique we previously developed to create cohesive ends to enhance ligation while reduce the formation of artificial tandem ligation products, primer extension approach coupled with biotinstreptavidin based purification technology to reduce non-specific amplifications and to increase flexibility in choice of enzymes applied to digest DNA, introduction of nano-scale magnetic particles to achieve a better separation, and digestion of DNA with a combination of enzymes to reduce the bias into amplification as a consequence of uneven distributions of restrictive recognition sites. We have demonstrated APE-PCR to be more convenient and efficient in PIS isolation, capable of amplification of more and larger specific PCR bands, with a lower non-specific background produced, fewer steps and less DNA samples required, at a lower cost. We have also shown that replacement of regular magnetic beads with nano-scale ones in the protocol can further increase its power. Moreover, we have examined the sensitivity of APE-PCR, and found that PISs can be recovered and analyzed, even with small amount of sample DNA.
Material and methods

Cell lines and culture
The leukemia cell lines used in this study were all derived from BXH-2 mice, and maintained as described previously . Briefly, cell lines including B139, B114, and highly cytosine arabinoside (Ara-C) resistant B117H and B140HA, were grown in ASM medium and incubated at 37
• C in a humidified atmosphere containing 5% CO2. All media and supplements, except noted individually, were obtained from Invitrogen (Carlsbad, CA, USA). On analysis, cells of logarithmic growth phase were collected with a viability of more than 98%, as determined by trypan blue exclusion assay.
Extraction of genomic DNA Genomic DNA was extracted from the cultured cells using the TIANamp Genomic DNA Kit (TianGen, Beijing, China), according to the manufacturer's instructions. The DNA samples were quantified and evaluated by spectrophotometry using the DU 800 Nucleic Acid/Protein Analyzer (Beckman Coulter, CA, USA).
APE-PCR protocol
Digestion. Genomic DNA was digested with a restriction enzyme cocktail containing Hind III, Pvu II and Xho I (Thermo, MA, USA), at 37
• C for 2∼3 hours. The digestion products were purified with AxyPrep T M PCR Clean-Up Kit (Axygen Co., CA, USA), according to the manufacturer's instructions. Briefly, Buffer PCR-A (3X sample volume) was added to the digestion products; mix well and transfer to the AxyPrep PCR column, centrifuge at 12,000×g for 1 min, wash with 700 µL of Buffer W2, and elute the DNA with H2O.
Extension. Digested DNA was incubated in a reaction buffer containing 1.5 mM MgCl2, 0.2 mM dNTPs, 20 pmol biotinylated primer Bio-AKVp7711, and 2.5 U Taq DNA polymerase, at 95
• C for 5 min, followed by 64
• C for 30 min and 72
• C for 20 min. The reaction product was purified with AxyPrep TM PCR Clean-Up Kit, again (performed as described above).
Purification. To capture the extension products, streptavidin-coupled magnetic particles (Dynabead purchased from Invitrogen Co., or NanoLink TM Streptavidin Magnetic Beads, as indicated) were washed and resuspended with 2X blocking and washing (BW) buffer containing 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2 M NaCl, mixed with the primer extension products, and incubated at room temperature (20∼25 • C) for 0.5∼2 hours. The biotin-bearing DNA fragments were captured using magnetic particle concentrator.
Ligation. The captured DNA was ligated to an appropriate amount of SplinkTA, using T4 DNA ligase (TaKaRa Co., Japan), by incubation at 16
• C for 16∼20 hours. SplinkTA was made by mixing equal molar amounts of oligonucleotide Splinkerette and PrimerLongTA, and incubating for 2 min at 92
• C before allowing it to slowly cool down to room temperature (20∼25
• C).
Primary and secondary PCR. The ligated biotinbearing DNA fragments were captured in magnetic particle concentrator and used as templates for primary PCR, which was carried out in the PCR buffer containing 1.5 mM MgCl2, 0.2 mM dNTPs, 20 pmol primer pAKV7774, 20 pmol primer P-short, and 2.5 U Taq DNA polymerase (TaKaRa Co., Japan), and programmed at 95 • C for 10 min. The PCR products were examined by electrophoresis on a 1% agarose gel. All primers were synthesized by Genewiz or Invitrogen, and are summarized in Table 1 .
Cloning of PCR products. Secondary PCR products were purified with AxyPrep TM PCR Clean-Up Kit (TianGen Co., Beijing, China) and ligated to the pMD 19-T vector (TaKaRa Co., Japan) according to the manual, followed by transformation, positive colony identification, and sequencing.
DNA sequence analysis
Genomic DNA sequences flanking PISs were analyzed using BLAST tool (Altschul et al. 1990 ) to search against Table 1 . Sequence (5' → 3') of oligonucleotides used in this study.
Name
Primer sequence PrimerLongTA CCTCCACTACGACTCACTGAAGGGCAAGCAGTCCTAACAACCATGT Splinkerette phos-CATGGTTGTTAGGACTGGAGGGGAAATCAATCCCCT Bio-AKVp7711 biotin-TCCAGGCTGCCATGCACGATGAC pAKV7774 CTTTGACCTCCTTGTCCGAAGTA P-short CCTCCACTACGACTCACTGAAGGGC pAKV8712 GCCAGTCCTCCGATAGACTGAG P-nested GGGCAAGCAGTCCTAACAACCATG Fig. 1 . A flow chart of APE-PCR protocol in cloning of genomic DNA sequences flanking a proviral insertion site. Genomic DNA (horizontal lines) bearing proviral genome sequence (black bars) is digested with a cocktail of restriction enzymes (X, Y and Z) that do not recognize the region downstream to the primers (horizontal arrow heads) to be used for primary and secondary PCR. The digested double-stranded DNA is denatured, followed by annealing of a provirus-specific 5' biotinylated (filled circle) primer to its complementary region on single-stranded DNA fragments, and immediate extension with Taq DNA polymerases, which frequently produce an additional adenosine (empty star) at the 3' end of DNA being synthesized. The primer extension products are then ligated to SplinkTA, a modified Splinkerette ending with a thymidine (filled star) (Yin & Largaespada 2007; Yin 2011 ). Subsequently, the biotinylated ligation products are purified with streptavidin-coated magnetic particles, and subjected to two continuous rounds of PCR, prior to cloning and sequencing of PCR products.
the Ensembl Mouse Genome Database (www.ensembl.org/ Mus musculus/).
Results and discussion
Because of the broad applications of insertional mutagenesis in understanding biology and advancing biotechniques, it is essential to develop methods of efficient recovery of the insertion sites of any given insertional mutagens. This study has introduced an improved protocol for the identification of PISs of BXH-2 MuLV. Our previous data showed that SplinkBlunt-PCR and STA-PCR each could not achieve a full recovery of PISs for some samples (Yin & Largaespada 2007) , suggestive of use of both protocols for a better PIS recovery. This, however, may not be effort-effective. The APE-PCR protocol, as illustrated in Fig. 1 , adopts the Addition technique we have previously developed that is based on creation of cohesive ends through the frequent formation of an extra adenosine at the 3' end by Taq DNA polymerases via the non-template polymerization mechanism, to both increase ligation efficiency and decrease the likelihood of forming artificial tandem ligation of blunt DNA fragments (Yin 2011) . This method also incorporates biotinylated primer extension, thereby not only maximizing its compatibility with digestions by a variety of restriction enzymes, but also removing the majority of non-specific template DNAs that would otherwise adversely affect the specificity and efficiency of downstream PCR.
At the outset of the experiments, genomic DNA from a virally negative cell lines was used as a negative control and results showed that this method could screen specific PISs (Fig. 2) . To examine the validity of our new protocol, we tested it on two cell lines, B117H and B139, both of which were derived from BXH-2 leukemia. As can be seen in Figure 3 , APE-PCR amplified more bands than SplinkBlunt-PCR for both cell lines. Surprisingly, we found that, in B117H, two large bands with the size of 3.5 kb and 3.8 kb, respectively, were produced by APE-PCR but absent from SplinkBlunt-PCR products (Fig. 3a) . Similarly, in another cell line B139, around 2-kb large PCR bands were generated only by APE-PCR (Fig. 3b) . We found that a few prominent bands detected by SplinkBlunt-PCR are very weak with APE-PCR and results analysis the APE-PCR can get more lanes and some lanes can be easily amplified. Subsequently, secondary PCR bands were cloned into pMD 19-T vector for sequencing. The results of sequencing and analysis of genomic DNA sequences flanking PISs are shown in Table 2 . The results showed the presence of BXH-2 MuLV tag sequence, confirming that the bands appearing on the gel were BXH-2 MuLV specific. These results indicated that APE-PCR could amplify large PIS-derived DNA fragments. Furthermore, APE-PCR gave rise to a low background and distinct bands, compared with SplinkBlunt-PCR, indicating that APE-PCR amplification was more specific than SplinkBlunt-PCR (Figs 3a,b) . The data presented here suggest that APE-PCR can detect PISs with a high efficiency compared with SplinkBlunt-PCR.
In line with the point of view by Leoni et al. (2011) , we chose the combination of restriction enzymes largely based on the recognition that any restriction enzymes of choice would not cut the sequence of BXH-2 ecotropic MuLV downstream to the locations of the primers to be used for subsequent PCR reactions. In addition, use of 4-bp cutters was supposed to result in more efficient recovery of PISs than 6-bp cutters. As examined in our earlier work (Yin & Largaespada 2007) , we found only one 4-cutter, Taq I, that did not cut the sequence of BXH-2 ecotropic MuLV downstream to where the PCR primers were located, and thus, could be used in our protocols. However, in order to make our protocol more broadly applicable to analysis of integrant DNA fragments beyond BXH-2 MuLV, we therefore chose, validated, and presented with the current 6-cutter restriction enzyme cocktail. However, this does not exclude the possible further improvements with 4-cutters to isolate insertion sites of other DNA integrants. Our results showed that this new combination of restriction enzymes, including Hind III, Pvu II and Xho I, produced similar number of PCR bands to that previously reported containing Bcl I, Taq I and BspLU11 I, demonstrating that alternative enzymes could be used (data not shown). We also found that, for purification of the primer extension product, AxyPrep TM PCR Clean-Up Kit worked as well as the more expensive Microcon YM-30 columns (Millipore).
Recently, nanotechnology has been shown to contribute significantly to biomedical researches. Unique properties offered by a variety of nano-materials, such as nano-quantum dots, carbon nanotubes, micelles and graphene, have facilitated biotechnology, drug delivery, diagnosis and therapy of diseases (Dubertret et al. 2002; Medintz et al. 2005; Davis et al. 2010; Sugahara et al. 2010; Alvarez-Erviti et al. 2011) . In APE-PCR, the application of nano-sized streptavidin-coupled magnetic beads (NanoLink TM , Solulink Co., diameter of 150∼850 nm) is one important component to purify DNA integrant specific fragments. Streptavidin-coupled beads served as a solid-phase matrix for simple and efficient binding of biotinylated oligonucleotides. Theoretically, reduction in the diameters of the beads can lead to an increased effective area ratio and load capacity, and a decreased likelihood of adverse impact, such as steric hindrance effect, imposed by the use of compact large magnetic beads. These advantages would combine to contribute to efficient binding and high-quality purification of target DNA fragments. Based on the reasoning, we tested the nano-scale magnetic beads replacing the micron-sized ones in APE-PCR amplification of DNA obtained from B114 cell line. As we anticipated, use of the nano-scale beads tended to generate more, clearer and larger PIS bands, compared with micron beads (Fig. 4) . Together, our data suggest that the nano-sized streptavidin magnetic beads can further enhance the strength of APE-PCR in the identification of PISs.
Because the availability of DNA samples is often limited, we went on to determine the sensitivity of APE-PCR. For this purpose, 0.01∼3 µg of genomic DNA extracted from each of four BXH-2 derived leukemia cell lines were subjected to APE-PCR. With the use of the nano-sized streptavidin magnetic beads, we found that DNA quantities in the range of 0.01∼3 µg were sufficient for amplification of PIS fragments (Fig. 5) ; however, decreasing DNA quantity down to 0.01 µg could lose some PCR products. Thus, although 1.5 µg of DNA is optimal in general, as low as 0.01 µg of DNA sample is sufficient for PISs cloning by APE-PCR.
In this work, we have developed an improved PCR-based method, APE-PCR, which is efficient, costeffective, and fast for cloning of PISs. The APE-PCR is characterized by the use of a restriction enzyme cocktail for DNA digestion, biotinylated Addition primer extention strategy coupled with SplinkTA ligation (Yin & Largaespada 2007; Yin 2011) , and nano-scale magnetic beads for a better enrichment of specific template DNAs. These advantages are combined to produce more and larger specific PIS amplicons, with a lower non-specific background produced, fewer steps and less DNA samples required, and flexibility in choice of restriction enzymes applied. A further modification of APE-PCR can be possibly made to achieve highthroughput isolation of BXH-2 PISs by using the pyrosequencing or other next generation sequencing methods (Mikkers et al. 2002; Uren et al. 2009; Volpicella et al. 2012) .
Since the research strategy of insertion site cloning has a variety of potential applications, the methods for this purpose have continued to be developed. A significant progress has recently been made in cloning approaches with improved efficiency and/or sensitivity. For example, Harkey et al. (2007) optimized linear amplification-mediated (LAM)-PCR by utilization of a multi-linker ligation followed by high-throughput shot-gun cloning of PCR products to improve the detection of lentiviral insertion sites in a rapid, costeffective way. Schmidt et al. (2007) described their modified LAM-PCR analyses, which featured initial preamplification of the retroviral vector-genome junctions prior to removal of non-target DNA via magnetic selection and restriction digestion, to achieve an impressive detection sensitivity of a single cell level. Gabriel et al. (2009) further developed a novel non-restrictive LAM-PCR approach, using single-stranded DNA ligation in combination with high-throughput sequencing, to be capable of comprehensive unbiased integration site retrieval in preclinical and clinical samples, eliminating restriction digestion and tolerating amplification inefficiency. Recently, Brady et al. (2011) introduced a transposon-based method in which simple use of transposase-mediated random integration of Mu DNA into target DNA provided an anchor for priming PCR, reducing recovery biases in restriction digestionbased methods and meantime, increasing the rate of recovering potential target sites. Our study showed that APE-PCR is well suited for cloning of insertion sites of BXH-2-derived murine leukemia virus. The number of recovered PISs is not only affected by the capacity of APE-PCR, but also determined by the abundance of proviral insertions present in the genomic DNA of leukemia cells derived from BXH-2 strain of mice. This strain of mouse represents a unique animal model to study the mechanisms underlying the development of acute myeloid leukemia (Yin et al. 2009 ). However, one of the key elements, the sufficient isolation of PISs, used to be a challenge. In the present work, the patterns of our PCR bands and the sequencing results have led us to the conclusion that APE-PCR works better than SplinkBlunt-PCR. Further exploration of improvements of APE-PCR is currently ongoing in our laboratory, by the combinatory use of high-throughput parallel sequencing technology, which may be able to recover subclonal insertions that might play some roles in leukemogenesis as well. It would be predicted that APE-PCR may have some rooms to develop further by incorporation of the latest advances, such as the abovementioned ideas.
Given its success in the isolation of PISs associated with BXH-2 leukemia, APE-PCR might be adaptable for the identification of PISs-associated with other retrovirally induced cancers or even for mapping of insertion sites of other types of insertional mutagens, such as transposons and retrotransposons (Devon et al. 1995; Collier et al. 2005; Yin & Largaespada 2007) . The technique may also be applicable to addressing a broad range of questions including determination of genomic integration sites of a transgene, of chromosomal breakpoints involved in deletion or translocation, and of gene regulatory regions. Furthermore, parts of the protocols that we have reported can be taken with or without modifications for biotechnical applications beyond PIS cloning. For example, the unique idea underlying the Addition technique, as described above, has recently been incorporated into the procedure of construction of DNA fragment library for high-throughput sequencing or next generation sequencing, which nowadays is being frequently employed for a wide variety of large genomic research projects.
